Browsing: biopharma nl

Supernus Pharmaceuticals and Indivior Pharmaceuticals, companies that built businesses in different areas of neuroscience, have reached a deal to combine…

Apnimed, a sleep disorders drug developer whose lead therapeutic candidate is under FDA review, raised $192 million in a stock…

In medical innovation, we prioritize evidence, outcomes, and economics. Metrics such as clinical endpoints, regulatory milestones, reimbursement pathways, and market…

Pharmaceutical companies often point to slow clinical trial enrollment as a chokepoint for drug development, but it’s no picnic for…

Johnson & Johnson, which was part of the wave of the first cell therapies, is now getting a next-generation contender…